Skip to content

20/20 BIOLABS, INC.

AIDX

CIK 0001139685

← back to feed
Revenue (TTM)
$2.05M
+16.7% YoY Q1 May 2026
Net Income (TTM)
−$3.74M
+32.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.76
+34.5% YoY Q1 May 2026
Gross Margin
29.6%
Q1 May 2026
Operating Margin
-162.9%
Q1 May 2026
Net Margin
-182.8%
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$4.22M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
10.61M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings